Literature DB >> 9226309

Large intracranial vessel occlusive vasculopathy after radiation therapy in children: clinical features and usefulness of magnetic resonance imaging.

M Omura1, N Aida, K Sekido, M Kakehi, S Matsubara.   

Abstract

PURPOSE: To assess the relationship between large intracranial vessel occlusive vasculopathy (vasculopathy) and radiation therapy, and to clarify the clinical efficacy of magnetic resonance (MR) imaging in the diagnosis and screening of the vasculopathy. METHODS AND MATERIALS: We retrospectively evaluated the medical records and serial MR images for 32 pediatric patients, in whom radiation therapy had been given to fields including the circle of Willis and major cerebral arteries. All children had periodically undergone follow-up neurologic assessment and MR imaging examinations at Kanagawa Children's Medical Center for more than one year after radiation therapy (range 1.3-14 years). Patients who had not remained free of tumor progression up to the time of final evaluation were excluded.
RESULTS: Vasculopathy developed in 6 of 32 patients 2-13 years after radiation therapy. Three of them presented with transient ischemic attacks (TIA) and the other three showed infarctions without preceding TIA. Steno-occlusive changes of major cerebral arteries were identified by MR imaging in all six patients, but not obtained in the remaining 26 patients. In the patients with TIA, MR imaging demonstrated steno-occlusive changes at the time of TIA, before irreversible infarction. They have been doing well subsequent to encephaloduroarteriosynangiosis. In the three patients who presented infarction without preceding TIA, MR imaging did not demonstrate the vascular change before the onset of infarction, and two of them developed neurologic deficits. The mean exposure dose for the circle of Willis and major cerebral arteries in these six patients was significantly higher than that in the remaining 26 patients without this sequela (61 Gy vs. 50 Gy, p < 0.05). The mean age at radiation therapy of the six patients was lower, but the difference was not significant.
CONCLUSION: The incidence of vasculopathy after radiation therapy has a considerable correlation with radiation dose and age at radiation therapy. MR examination is useful for the diagnostic evaluation of vasculopathy, and it is also effective in screening for vasculopathy in patients with TIA, and may be helpful in the prevention of neurologic sequela.

Entities:  

Mesh:

Year:  1997        PMID: 9226309     DOI: 10.1016/s0360-3016(97)82497-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  25 in total

1.  Recurrent stroke in childhood cancer survivors.

Authors:  Heather J Fullerton; Kayla Stratton; Sabine Mueller; Wendy W Leisenring; Greg T Armstrong; Rita E Weathers; Marilyn Stovall; Charles A Sklar; Robert E Goldsby; Les L Robison; Kevin R Krull
Journal:  Neurology       Date:  2015-08-26       Impact factor: 9.910

2.  Whole-Genome Sequencing of Childhood Cancer Survivors Treated with Cranial Radiation Therapy Identifies 5p15.33 Locus for Stroke: A Report from the St. Jude Lifetime Cohort Study.

Authors:  Kevin R Krull; Yutaka Yasui; Yadav Sapkota; Yin Ting Cheung; Wonjong Moon; Kyla Shelton; Carmen L Wilson; Zhaoming Wang; Daniel A Mulrooney; Jinghui Zhang; Gregory T Armstrong; Melissa M Hudson; Leslie L Robison
Journal:  Clin Cancer Res       Date:  2019-08-28       Impact factor: 12.531

3.  Large Vessel Arteriopathy After Cranial Radiation Therapy in Pediatric Brain Tumor Survivors.

Authors:  Matthew Nordstrom; Erin Felton; Katherine Sear; Benita Tamrazi; Joseph Torkildson; Karen Gauvain; Daphne A Haas-Kogan; Josephine Chen; Benedict Del Buono; Anuradha Banerjee; David Samuel; David Saloner; Bing Tian; Erika Roddy; Christopher Hess; Heather Fullerton; Sabine Mueller
Journal:  J Child Neurol       Date:  2018-04       Impact factor: 1.987

Review 4.  Iatrogenic carotid artery injury in neurosurgery.

Authors:  Joji Inamasu; Bernard H Guiot
Journal:  Neurosurg Rev       Date:  2005-08-10       Impact factor: 3.042

Review 5.  Proton therapy for paediatric CNS tumours - improving treatment-related outcomes.

Authors:  Vinai Gondi; Torunn I Yock; Minesh P Mehta
Journal:  Nat Rev Neurol       Date:  2016-05-20       Impact factor: 42.937

Review 6.  High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillance.

Authors:  Melissa M Hudson; Daniel A Mulrooney; Daniel C Bowers; Charles A Sklar; Daniel M Green; Sarah S Donaldson; Kevin C Oeffinger; Joseph P Neglia; Anna T Meadows; Leslie L Robison
Journal:  J Clin Oncol       Date:  2009-03-16       Impact factor: 44.544

7.  Headache as a risk factor for neurovascular events in pediatric brain tumor patients.

Authors:  Sarah M Kranick; Cynthia J Campen; Scott E Kasner; Sudha K Kessler; Robert A Zimmerman; Robert A Lustig; Peter C Phillips; Lauren A Beslow; Rebecca Ichord; Michael J Fisher
Journal:  Neurology       Date:  2013-03-13       Impact factor: 9.910

Review 8.  Cerebrovascular stenosis in neurofibromatosis type 1 and utility of magnetic resonance angiography: our experience and literature review.

Authors:  Felice D'Arco; Alessandra D'Amico; Ferdinando Caranci; Nilde Di Paolo; Daniela Melis; Arturo Brunetti
Journal:  Radiol Med       Date:  2013-12-03       Impact factor: 3.469

9.  Cranial irradiation increases risk of stroke in pediatric brain tumor survivors.

Authors:  Cynthia J Campen; Sarah M Kranick; Scott E Kasner; Sudha K Kessler; Robert A Zimmerman; Robert Lustig; Peter C Phillips; Phillip B Storm; Sabrina E Smith; Rebecca Ichord; Michael J Fisher
Journal:  Stroke       Date:  2012-09-11       Impact factor: 7.914

10.  Radiation, atherosclerotic risk factors, and stroke risk in survivors of pediatric cancer: a report from the Childhood Cancer Survivor Study.

Authors:  Sabine Mueller; Heather J Fullerton; Kayla Stratton; Wendy Leisenring; Rita E Weathers; Marilyn Stovall; Gregory T Armstrong; Robert E Goldsby; Roger J Packer; Charles A Sklar; Daniel C Bowers; Leslie L Robison; Kevin R Krull
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-05-14       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.